Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aravindhan Veerapandiyan

Concepts (215)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscular Dystrophy, Duchenne
7
2024
23
3.300
Why?
Muscular Atrophy, Spinal
5
2024
13
3.110
Why?
Oligonucleotides
4
2020
81
2.120
Why?
Genetic Therapy
5
2024
117
1.690
Why?
Pneumonia, Viral
3
2020
170
1.680
Why?
Coronavirus Infections
3
2020
179
1.650
Why?
Spastic Paraplegia, Hereditary
2
2022
2
1.620
Why?
Mutation
12
2023
1292
1.530
Why?
Disease Management
2
2020
175
1.260
Why?
Dystonic Disorders
2
2023
6
1.230
Why?
Pandemics
4
2022
566
1.150
Why?
Humans
48
2024
49898
0.990
Why?
Spasms, Infantile
2
2018
28
0.980
Why?
Child
23
2024
6844
0.980
Why?
Epilepsy
2
2022
176
0.960
Why?
Neuromuscular Diseases
1
2024
30
0.910
Why?
Spinal Muscular Atrophies of Childhood
2
2020
9
0.900
Why?
Recombinant Fusion Proteins
2
2024
186
0.890
Why?
Peroneal Neuropathies
2
2021
5
0.890
Why?
Intellectual Disability
2
2022
125
0.880
Why?
Dystonia
1
2023
10
0.860
Why?
Dystrophin
4
2024
7
0.850
Why?
Nerve Tissue Proteins
2
2021
192
0.800
Why?
Myasthenic Syndromes, Congenital
1
2021
7
0.770
Why?
Chromosomes, Human, Pair 22
2
2011
39
0.740
Why?
Fasciculation
1
2020
2
0.730
Why?
Isaacs Syndrome
1
2020
2
0.730
Why?
Hereditary Sensory and Motor Neuropathy
1
2020
3
0.730
Why?
Seizures
3
2018
195
0.720
Why?
Male
28
2024
25437
0.710
Why?
Muscular Dystrophies
1
2020
15
0.710
Why?
Myopathies, Structural, Congenital
1
2020
10
0.710
Why?
Codon, Nonsense
1
2020
26
0.700
Why?
Adolescent
16
2024
6414
0.700
Why?
Anticonvulsants
2
2012
121
0.700
Why?
Apoptosis Regulatory Proteins
1
2020
85
0.690
Why?
Charcot-Marie-Tooth Disease
1
2019
8
0.680
Why?
Phenotype
3
2020
728
0.680
Why?
Glucocorticoids
3
2020
229
0.680
Why?
Epstein-Barr Virus Infections
1
2020
29
0.680
Why?
Encephalitis
2
2017
40
0.650
Why?
Adaptor Proteins, Signal Transducing
1
2020
197
0.650
Why?
Multiple Sclerosis
1
2019
63
0.650
Why?
Consensus
1
2020
155
0.650
Why?
Infant
9
2020
3572
0.640
Why?
Chromosome Duplication
1
2018
7
0.630
Why?
Survival of Motor Neuron 1 Protein
1
2018
3
0.630
Why?
Child, Preschool
13
2024
3875
0.620
Why?
Munc18 Proteins
1
2018
3
0.620
Why?
Spinal Puncture
1
2018
16
0.620
Why?
Microfilament Proteins
1
2018
42
0.610
Why?
Electroencephalography
6
2018
304
0.610
Why?
Epilepsies, Myoclonic
1
2018
12
0.610
Why?
Head
1
2018
70
0.600
Why?
Chromosomes, Human, Pair 1
1
2018
92
0.600
Why?
Chromosome Deletion
3
2018
138
0.580
Why?
Delivery of Health Care
1
2020
308
0.570
Why?
Central Nervous System Diseases
1
2017
26
0.570
Why?
Pedigree
3
2022
125
0.560
Why?
Attention Deficit Disorder with Hyperactivity
1
2018
173
0.540
Why?
Carrier Proteins
1
2018
302
0.540
Why?
Muscular Diseases
2
2020
61
0.520
Why?
Female
20
2024
26560
0.480
Why?
DiGeorge Syndrome
2
2012
17
0.470
Why?
Emergency Service, Hospital
1
2018
487
0.460
Why?
Tomography, X-Ray Computed
1
2018
1150
0.420
Why?
Brain
2
2018
1310
0.410
Why?
Epilepsy, Complex Partial
1
2012
3
0.400
Why?
Carbamazepine
1
2012
13
0.400
Why?
Epilepsy, Tonic-Clonic
1
2011
3
0.380
Why?
Pyridoxal Phosphate
1
2011
10
0.370
Why?
Cephalometry
1
2011
18
0.370
Why?
Myoglobinuria
1
2010
2
0.370
Why?
Triazines
1
2011
24
0.370
Why?
Epilepsy, Absence
1
2011
11
0.370
Why?
Ocular Motility Disorders
1
2011
17
0.370
Why?
BRCA2 Protein
1
2010
16
0.360
Why?
Velopharyngeal Insufficiency
1
2011
16
0.360
Why?
Pseudolymphoma
1
2010
4
0.360
Why?
Retrospective Studies
7
2021
6123
0.360
Why?
Prednisolone
3
2020
55
0.360
Why?
Mutation, Missense
1
2010
103
0.350
Why?
Treatment Outcome
5
2024
5176
0.340
Why?
Drug Overdose
1
2011
160
0.320
Why?
Young Adult
8
2024
4029
0.300
Why?
Diagnosis, Differential
3
2020
1036
0.300
Why?
Follow-Up Studies
3
2021
2175
0.250
Why?
Drug Therapy, Combination
2
2020
380
0.250
Why?
Muscle, Skeletal
1
2010
769
0.240
Why?
Heterozygote
2
2023
81
0.240
Why?
Genetic Vectors
1
2024
128
0.230
Why?
Dependovirus
1
2024
103
0.220
Why?
Histone-Lysine N-Methyltransferase
1
2023
57
0.210
Why?
Magnetic Resonance Imaging
3
2018
1525
0.200
Why?
Adenosine Triphosphatases
1
2022
87
0.200
Why?
Adult
8
2024
13346
0.200
Why?
Semaphorins
1
2021
3
0.200
Why?
Atrophy
1
2022
38
0.200
Why?
Patient Care Planning
1
2022
67
0.190
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2021
4
0.190
Why?
Cell Adhesion Molecules
1
2021
87
0.190
Why?
Cohort Studies
2
2018
1403
0.190
Why?
Receptors, Cell Surface
1
2021
120
0.180
Why?
Introns
2
2018
50
0.180
Why?
Muscle Cramp
1
2020
5
0.180
Why?
Recovery of Function
1
2021
187
0.170
Why?
Health Services Accessibility
1
2024
417
0.170
Why?
Flavoproteins
1
2019
5
0.170
Why?
Injections, Spinal
1
2019
19
0.170
Why?
Palliative Care
1
2022
185
0.170
Why?
Phosphoric Monoester Hydrolases
1
2019
21
0.170
Why?
Physical Endurance
1
2019
30
0.170
Why?
Hand Strength
1
2019
22
0.170
Why?
Facial Paralysis
1
2020
23
0.170
Why?
Muscle Weakness
1
2020
44
0.170
Why?
Membrane Proteins
1
2022
347
0.170
Why?
Neurologic Examination
1
2019
76
0.170
Why?
Steroids
1
2019
56
0.170
Why?
Age of Onset
1
2019
108
0.170
Why?
Abnormalities, Multiple
2
2011
167
0.160
Why?
Age Factors
3
2018
1092
0.160
Why?
Scoliosis
1
2019
60
0.160
Why?
Aminomethyltransferase
1
2018
1
0.160
Why?
Spinal Fusion
1
2019
69
0.160
Why?
Hyperglycinemia, Nonketotic
1
2018
5
0.160
Why?
Hyperammonemia
1
2018
20
0.160
Why?
Activities of Daily Living
1
2019
174
0.160
Why?
Lumbosacral Region
1
2018
12
0.160
Why?
X-Rays
1
2018
55
0.160
Why?
Anti-Inflammatory Agents
1
2019
160
0.150
Why?
Neuraminidase
1
2018
3
0.150
Why?
Mucolipidoses
1
2018
4
0.150
Why?
Pons
1
2017
33
0.140
Why?
Methylprednisolone
1
2017
38
0.140
Why?
Prevalence
1
2020
956
0.140
Why?
Brain Stem
1
2017
56
0.140
Why?
Disease Progression
1
2019
820
0.140
Why?
Cross-Sectional Studies
2
2019
1573
0.130
Why?
Quality of Life
1
2022
837
0.130
Why?
Middle Aged
4
2024
12285
0.130
Why?
T-Lymphocytes
1
2017
328
0.120
Why?
Aged
3
2021
9447
0.120
Why?
RNA, Messenger
1
2018
1099
0.120
Why?
Chronic Disease
1
2017
565
0.120
Why?
Antibodies
2
2012
151
0.120
Why?
Kv1.1 Potassium Channel
1
2013
2
0.110
Why?
Caregivers
2
2024
212
0.100
Why?
Dipeptides
1
2012
22
0.100
Why?
Aspartic Acid
1
2012
49
0.100
Why?
Folic Acid Deficiency
1
2012
43
0.100
Why?
Folate Receptor 1
1
2012
25
0.100
Why?
Prefrontal Cortex
1
2012
81
0.100
Why?
Ear
1
2011
17
0.100
Why?
Hypoparathyroidism
1
2011
5
0.100
Why?
Immune System Diseases
1
2011
8
0.100
Why?
Facies
1
2011
35
0.100
Why?
Eye Abnormalities
1
2011
24
0.100
Why?
Nose
1
2011
31
0.090
Why?
Epilepsies, Partial
1
2011
12
0.090
Why?
Platybasia
1
2011
5
0.090
Why?
Frontal Lobe
1
2011
47
0.090
Why?
Infant, Newborn
1
2018
2729
0.090
Why?
Receptors, N-Methyl-D-Aspartate
1
2011
127
0.090
Why?
Glycogen Storage Disease Type III
1
2010
1
0.090
Why?
Glycogen Debranching Enzyme System
1
2010
2
0.090
Why?
Cervical Vertebrae
1
2011
58
0.090
Why?
Genetic Heterogeneity
1
2010
18
0.090
Why?
Genetic Predisposition to Disease
1
2013
507
0.090
Why?
Mental Disorders
2
2024
396
0.090
Why?
Cognition Disorders
1
2011
199
0.090
Why?
Syndrome
1
2010
237
0.090
Why?
Cleft Palate
1
2011
75
0.090
Why?
Brain Mapping
1
2011
227
0.080
Why?
United States
1
2020
4878
0.080
Why?
Lymph Nodes
1
2010
257
0.080
Why?
Myocardium
1
2010
443
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1354
0.070
Why?
Skin
1
2010
415
0.070
Why?
Exercise
1
2010
493
0.070
Why?
Heart Defects, Congenital
1
2011
584
0.060
Why?
Delphi Technique
1
2024
54
0.060
Why?
Myocarditis
1
2024
45
0.050
Why?
Azo Compounds
1
2022
10
0.050
Why?
Pilot Projects
1
2024
702
0.050
Why?
Health Personnel
1
2024
251
0.050
Why?
Electrodiagnosis
1
2021
12
0.050
Why?
Genetic Association Studies
1
2021
115
0.050
Why?
Pyrimidines
1
2022
192
0.050
Why?
Homozygote
1
2018
56
0.040
Why?
Prospective Studies
1
2024
2345
0.040
Why?
Signal Transduction
1
2021
1608
0.030
Why?
Flurothyl
1
2013
1
0.030
Why?
Kindling, Neurologic
1
2013
3
0.030
Why?
Aged, 80 and over
1
2021
3136
0.030
Why?
Mice, Mutant Strains
1
2013
71
0.030
Why?
Animals, Newborn
1
2013
367
0.030
Why?
Protons
1
2012
67
0.020
Why?
Hippocampus
1
2013
219
0.020
Why?
Chi-Square Distribution
1
2012
275
0.020
Why?
Magnetic Resonance Spectroscopy
1
2012
244
0.020
Why?
Autoantibodies
1
2011
114
0.020
Why?
Anisotropy
1
2011
63
0.020
Why?
Drug Resistance
1
2011
64
0.020
Why?
Video Recording
1
2011
79
0.020
Why?
Neuropsychological Tests
1
2012
336
0.020
Why?
Diffusion Magnetic Resonance Imaging
1
2011
123
0.020
Why?
Sequence Homology, Amino Acid
1
2010
145
0.020
Why?
Exons
1
2010
96
0.020
Why?
Amino Acid Sequence
1
2010
579
0.020
Why?
Molecular Sequence Data
1
2010
799
0.020
Why?
Disease Models, Animal
1
2013
1411
0.020
Why?
Mice, Inbred C57BL
1
2013
1777
0.020
Why?
Case-Control Studies
1
2011
1128
0.020
Why?
Mice
1
2013
5658
0.010
Why?
Animals
1
2013
13100
0.010
Why?
Veerapandiyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description